In the current study, we provide evidence that NRF2-mediated KYNU upregulation extends beyond LUAD, as evidenced in the context of PDAC, and that the upregulation of the NRF2–KYNU axis is a frequent phenomenon across several cancer types. This evidence concerns the gene NFE2L2 and cancer.